Pfizer's Inversion Of $160 Billion Allergan Deal Called Off
/Pfizer terminated it's $160 billion agreement to aquire Botox marker Allergan.
It's something of a victory for lawmakers looking to stop corporate mergers designed to reduce taxes in the US. It would have cut Pfizer's tax bill by 'relocating' the company to Ireland where Allergan is registered.
In backing out of the deal Phiser will have to pay Allergan up to $400 million for it's expenses according to the merger aggrement. (Who negotiated that?)
The Treasury Dept. also implement a new rule that does not allow stock accumulated through a foreign company's U.S. deals in the last 3 years to count towards the "book value" needed to meet this new inversion threshold.






Protect your clinic and profits in 24 hours.
This Embezzlement & Employee Theft Scams training course gives you a practical roadmap to protect your clinic, your patients, your reputation, and your bank account.
Taking cash payments in the treatment room, stealing Botox and fillers to inject their own patients, ordering fraud, trading extra services for large tips, or stealing your client database to sell or use... This new course on beating embezzlement and employee theft schemes uncovers the hidden tactics behind how these scams work, and how to discover them before they kill your clinic.
Get This Free Training Academy Course